Menu
GWAS Study

Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Sherva R, Baldwin CT, Inzelberg R et al.

21098978 PubMed ID
GWAS Study Type
5543 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SR
Sherva R
BC
Baldwin CT
IR
Inzelberg R
VB
Vardarajan B
CL
Cupples LA
LK
Lunetta K
BA
Bowirrat A
NA
Naj A
PM
Pericak-Vance M
FR
Friedland RP
FL
Farrer LA
Chapter II

Abstract

Summary of the research findings

Alzheimer's disease (AD) is highly prevalent in Wadi Ara despite the low frequency of apolipoprotein E ε4 in this genetically isolated Arab community in northern Israel. We hypothesized that the reduced genetic variability in combination with increased homozygosity would facilitate identification of genetic variants that contribute to the high rate of AD in this community. AD cases (n = 124) and controls (n = 142) from Wadi Ara were genotyped for a genome-wide set of more than 300,000 single nucleotides polymorphisms (SNPs) which were used to calculate measures of population stratification and inbreeding, and to identify regions of autozygosity. Although a high degree of relatedness was evident in both AD cases and controls, controls were significantly more related and contained more autozygous regions than AD cases (p = 0.004). Eight autozygous regions on seven different chromosomes were more frequent in controls than the AD cases, and 116 SNPs in these regions, primarily on chromosomes 2, 6, and 9, were nominally associated with AD. The association with rs3130283 in AGPAT1 on chromosome 6 was observed in a meta-analysis of seven genome-wide association study (GWAS) datasets. Analysis of the full Wadi Ara GWAS dataset revealed 220 SNP associations with AD at p ≤ 10⁻⁵, and seven of these were confirmed in the replication GWAS datasets (p < 0.05). The unique population structure of Wadi Ara enhanced efforts to identify genetic variants that might partially explain the high prevalence of AD in the region. Several of these variants show modest evidence for association in other Caucasian populations.

124 Isreali Arab cases, 142 Israeli Arab controls

Chapter III

Study Statistics

Key metrics and study information

5543
Total Participants
GWAS
Study Type
Yes
Replicated
1,930 European ancestry cases, 1,312 European ancestry controls, 931 European ancestry and Ashkenazi Jewish cases, 1,104 European ancestry and Ashkenazi Jewish controls
Replication Participants
European, Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
Israel
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.